Skip to main content
. 2020 Mar;21(3):667–673. doi: 10.31557/APJCP.2020.21.3.667

Table 3.

Association between the Combination of Telomere–Related Genetic Polymorphisms and the Risk of IPF

Presence of "at-risk" genotype
Cases/controls Adjusted OR a (95% CI) P-value Adjusted OR a (95% CI) P-value
TERC
OBFC1
TERT
rs1881984 rs11191865 rs2736100
0 0 0 13/73 1.00 (Reference) 1.00 (Reference)
1 0 0 17/56 1.22 (0.43–3.44) 0.713 1.78 (0.77–4.08)
0 1 0 23/69 1.81 (0.69–4.70) 0.224 0.176
0 0 1 20/43 2.42 (0.89–6.55) 0.083
1 1 0 20/44 3.06 (1.02–9.17) 0.046 2.84 (1.20–6.73)
1 0 1 21/34 2.31 (0.82–6.47) 0.111 0.018
0 1 1 20/34 3.32 (1.12–9.82) 0.03
1 1 1 21/26 3.50 (1.16–10.62) 0.027 3.51 (1.16–10.59) 0.026
Ptrend = 0.003

95% CI, 95% confidence interval; OR, odds ratio; Based on recessive model; a, Adjusted for age, sex and smoking status.

HHS Vulnerability Disclosure